Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06860880 · ClinicalTrials.gov registry record · NA

Combating Cancer-Related Fatigue: A Personalized Supportive Care Program

A NA study of Lymphoma and Chronic Lymphocytic Leukemia, sponsored by UNC Lineberger Comprehensive Cancer Center.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06860880 is a NA study of Lymphoma and Chronic Lymphocytic Leukemia that is actively recruiting participants, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 40 participants, below the 484-participant average among 299 other Lymphoma trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06860880, a NA study of Lymphoma and Chronic Lymphocytic Leukemia, is actively recruiting participants, sponsored by UNC Lineberger Comprehensive Cancer Center.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This health services study will assess a multidisciplinary intervention program directed at fatigue mitigation among patients diagnosed with indolent lymphomas. Specifically, 30 subjects with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and 10 subjects with Follicular Lymphoma (FL), marginal zone lymphoma (MZL), lymphoplasmacytic lymphoma (LPL), Waldenström's Macroglobulinemia, or Cutaneous T Cell Lymphoma (CTCL) will be included.

Interventions

  • OTHER Exercise
  • OTHER Diet

Study Locations (1)

North Carolina

  • North Carolina Basnight Cancer Hospital - Chapel Hill

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-06-03
Est. Completion 2026-12-31
Phase NA

What the Registry Record Tells You About NCT06860880

The ClinicalTrials.gov registry entry for NCT06860880 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 484-participant average among 299 other Lymphoma trials with a reported enrollment target (92% lower). The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.

The record links to 9 conditions, with Lymphoma appearing as the primary indexed condition, and to 2 interventions - of which Exercise is the first listed.

NCT06860880 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT06860880 about?

NCT06860880 is a clinical study titled "Combating Cancer-Related Fatigue: A Personalized Supportive Care Program". This health services study will assess a multidisciplinary intervention program directed at fatigue mitigation among patients diagnosed with indolent lymphomas. Specifically, 30 subjects with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and 10 subjects with Follicular Lymphoma (...

What is the current status of trial NCT06860880?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-06-03. Estimated completion is 2026-12-31.

What conditions does trial NCT06860880 study?

This clinical trial studies the following conditions: Lymphoma, Chronic Lymphocytic Leukemia, Follicular Lymphoma, Small Lymphocytic Lymphoma, Marginal Zone Lymphoma.

What interventions are being tested in trial NCT06860880?

The interventions under investigation include: Exercise (OTHER), Diet (OTHER).

Who is sponsoring clinical trial NCT06860880?

This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06860880 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lymphoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.